Preventing Fractures in Postmenopausal Women with Osteoporosis: A Review of Recent Controlled Trials of Antiresorptive Agents

Author： Hochberg M.

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.17, Iss.4, 2000-10, pp. : 317-330

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of Antiresorptive Agents for Preventing Fractures in Japanese Patients with an Increased Fracture Risk: Review of the Literature

By Iwamoto Jun

Drugs & Aging, Vol. 29, Iss. 3, 2012-03 ,pp. : 191-203

Adis International

Access to resources Recommend Favorite

Pharmacological Management of Osteoporosis in Postmenopausal Women: A Comparative Review

By Reid I.R.

Drugs & Aging, Vol. 15, Iss. 5, 1999-11 ,pp. : 349-363

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Multi-Therapy Treatment Strategies in the Prevention of Vertebral Fractures in Postmenopausal Women with Osteoporosis

By Rosner A.J.

PharmacoEconomics, Vol. 14, Iss. 5, 1998-11 ,pp. : 559-573

Adis International

Access to resources Recommend Favorite

New horizons for zoledronic acid: results of the HORIZON trials in postmenopausal women with osteoporosis and after hip fracture

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 4, 2008-03 ,pp. : 663-668

Informa Healthcare

Access to resources Recommend Favorite

Risedronate for prevention and treatment of osteoporosis in postmenopausal women

By Recker Robert R Barger-Lux Janet

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 3, 2005-03 ,pp. : 465-477

Informa Healthcare

Access to resources Recommend Favorite